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Tilakavati Karupaiah1 and Kalyana Sundram2*Abstract
Background: Postprandial lipemia (PL) contributes to coronary artery disease. The fatty acid composition of dietary
fats is potentially a modifiable factor in modulating PL response.
Methods: This human postprandial study evaluated 3 edible fat blends with differing polyunsaturated to saturated
fatty acids (P/S) ratios (POL = 0.27, AHA = 1.00, PCAN = 1.32). A cross-over design included mildly
hypercholestrolemic subjects (9 men and 6 women) preconditioned on test diets fats at 31% energy for 7 days
prior to the postprandial challenge on the 8th day with 50 g test fat. Plasma lipids and lipoproteins were monitored
at 0, 1.5, 3.5, 5.5 and 7 hr.
Results: Plasma triacylglycerol (TAG) concentrations in response to POL, AHA or PCAN meals were not significant
for time x test meal interactions (P > 0.05) despite an observed trend (POL > AHA > PCAN). TAG area-under-the-
curve (AUC) increased by 22.58% after POL and 7.63% after PCAN compared to AHA treatments (P > 0.05). Plasma
total cholesterol (TC) response was not significant between meals (P > 0.05). Varying P/S ratios of test meals
significantly altered prandial high density lipoprotein-cholesterol (HDL-C) concentrations (P < 0.001) which increased
with decreasing P/S ratio (POL > AHA > PCAN). Paired comparisons was significant between POL vs PCAN (P = 0.009)
but not with AHA or between AHA vs PCAN (P > 0.05). A significantly higher HDL-C AUC for POL vs AHA (P = 0.015)
and PCAN (P = 0.001) was observed. HDL-C AUC increased for POL by 25.38% and 16.0% compared to PCAN and
AHA respectively. Plasma low density lipoprotein-cholesterol (LDL-C) concentrations was significant (P = 0.005)
between meals and significantly lowest after POL meal compared to PCAN (P = 0.004) and AHA (P > 0.05) but not
between AHA vs PCAN (P > 0.05). AUC for LDL-C was not significant between diets (P > 0.05). Palmitic (C16:0),
oleic (C18:1), linoleic (C18:2) and linolenic (C18:3) acids in TAGs and cholesteryl esters were significantly modulated
by meal source (P < 0.05).
Conclusions: P/S ratio of dietary fats significantly affected prandial HDL-C levels without affecting lipemia.
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Plasma triacylglycerol (TAG) in the post-meal state
mainly comprises triacylglycerol-rich lipoproteins (TRL)
carried by chylomicrons [1]. With human eating patterns
reflecting a postprandial state in excess of 16 h per day,
the fed state represents a major portion of this metabolic
transition. Elevated TAG triggers a chain of metabo-
lic reactions that may reduce high density lipoprotein-
cholesterol (HDL-C), promote formation of small dense
low density lipoprotein (LDL) particles and activate
prothrombotic factor FVII [2-4]. The induction of endo-
thelial dysfunction as well as a prothrombic state may
contribute to cardiovascular dysfunction [5,6]. Thus the
post-meal state, its resulting postprandial lipemia and in-
creased generation of TRL are recognized as modifiable
cardiovascular disease (CVD) risk factors [7]. In fact
prolonged circulation of TRL and suppression of HDL-C
concentrations are independently linked to atheroge-
nicity progression and early death in type 2 diabetes with
similar associations observed in metabolic syndrome,
obesity and hypertriglyceridemia [8,9].
Current dietary fatty acid recommendations in the
Adult Treatment Panel (ATP) III guidelines focus on
reduction of saturated fatty acids (SFA) to <7% en, in-
creasing monounsaturated fatty acids (MUFA) as a re-
placement for SFA, maintaining polyunsaturated fatty
acids (PUFA) at 10% en and reduction or elimination of
trans fatty acids (TFA) [7,10]. TFA link to CVD has
resulted in actions to remove TFA from the food supply
chain. Their replacement options include substituting
partially hydrogenated fatty acids with SFA from natural
fat(s) or specifically designed fully hydrogenated inte-
resterified fat containing SFAs made up mostly of stearic
acid [11-14]. The ideal fatty acid replacement is postu-
lated to reduce cardiovascular risk factors compared to
TFA. A consensus opinion examining these options re-
commended further interventional and observational
studies to fully understand the tradeoffs inherent in the
proposed recommendation [15]. Recommendations sup-
porting the reduction of SFAs to reduce coronary heart
disease (CHD) risk are now been questioned on the basis
that insufficient evidence exists to judge the effect on
CHD risk of replacing SFAs with MUFAs [16]. Addi-
tionally many clinical trials evaluate humans in the
fasted state but reports on the postprandial lipemic state
is comparatively few. The effect of diet on a single
biomarker such as lowering low density lipoprotein-
cholesterol (LDL-C) is now considered insufficient
evidence to assess CHD risk [17]. The combination of
multiple biomarkers and the use of clinical endpoints
are deemed useful to elucidate the mechanistic effects
of diet on CHD.
Given CVD risk associations with enhanced lipe-
mia, most initial research has targeted ‘fat load’ or‘fat tolerance’ tests to differentiate responses between
healthy subjects and those with metabolic abnormalities
[1,2]. However the effect of individual dietary fatty acids
on postprandial lipid metabolism remains to be fully
addressed given the diversity of dietary fats and oils avai-
lable for human consumption. Evaluation of physico-
chemical properties of oral fat meals suggests their fatty
acid composition determines chylomicron size post-meal,
which affects the rates of digestion and absorption [18].
This ultimately characterizes postprandial lipid response.
Attenuation of prandial TAG responses has been shown
with diets rich in n-3 PUFAs [19]. Studies using single fat
meals to produce different SFA, MUFA and n-6 PUFA-
rich diets report either a non-differentiated lipemic beha-
vior or exacerbated or reduced TAG responses [19-21]. A
recent study in making comparisons between SFA classes
using palmitic-rich, stearic-rich or lauric +myristic-rich
fats, found that slower prandial fat clearance was associ-
ated with increasing chain length of the saturates [22].
The newer interesterified fats with stereospecific reposi-
tioning of fatty acids on TAG structures have also been in-
vestigated postprandially [23].
What is the effect of a single meal that is rich in either
n-6 PUFA or MUFA compared to a SFA-rich meal as a
modifiable factor for eliciting a lesser prandial response
and a faster return to the fasting state? To date post-
prandial studies comparing either the influence of a
high-PUFA diet or a high-MUFA diet on lipemia are
limited. The object of this study therefore was to evalu-
ate single fat challenges of varying fatty acid polyunsa-
turated/saturated (P/S) ratios incorporated into test-meal
challenges on postprandial lipoprotein and TAG responses
in normal to mildly hypercholesterolemic humans.
Methods
Protocol
This study protocol was approved by the institutional
ethics committee of the National University of Malaysia.
Subjects were staff and students of a teacher training
centre in Kuala Lumpur, Malaysia. Both normocho-
lesterolemic (n = 9) and mildly hypercholesterolemic
(n = 6) subjects without a history of atherosclerotic dis-
ease or hypertension were recruited. They were all non-
smokers and did not consume any alcohol. None were
on any prescribed medication, nutritional supplementa-
tion or weight-loss programs. Additionally, female sub-
jects were not on oral contraceptives. Subjects were
thoroughly briefed on the study protocol and gave their
signed informed consent for participation in the study.
They had the freedom to drop out from the study at any-
time. Subject demographics were (mean ± SD): age, 35.5 ±
4.7 y ( range: 29 to 40 y); body mass index, 21.8 ± 2.3 kg/m2
(range: 17.3 to 26.7 kg/m2); total cholesterol, 5.26 ±
0.78 mmol/L (range: 3.97 to 6.90 mmol/L); triacylglycerol,
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cholesterol, 3.09 ± 0.62 mmol/L (range: 2.60 to 4.72 mmol/L);
and HDL-cholesterol, 1.64 ± 0.27 mmol/L (range: 1.32 to
2.20 mmol/L) [Table 1].
Study design
The study was designed to evaluate the postprandial ef-
fects of 3 dietary fatty acid permutations differing in
their PUFA and SFA content (P/S ratios 0.27, 1.00 and
1.32). Subjects were randomly assigned into 2 groups
(Group A with 5 men and 3 women and Group B with 4
men and 3 women) which alternated between 3 diet
rotations in a cross-over design. Prandial testing and
assignment into groups for women was scheduled ac-
cording to their menstrual cycle.
Breakfast, lunch and high tea meals were provided
from a standard menu for the 7-day period leading to
each postprandial investigation. This standardized menu
plan was repeated for all 3 test fat rotations, which each
group underwent with all meals prepared by a trained
caterer and supervised by a dietitian. Portion size and
protocols for incorporation of the test oils into meals pre-
paration were fixed. The menu utilized typical Malaysian
recipes and was constructed according to the following
meal plan: 1) for breakfast, a cereal dish and a snack
item cooked with the test fat was served with either cof-
fee or tea, 2) lunch included fish or chicken and two
vegetables cooked with the test fat and accompanied by
rice and fruits and 3) for high tea, a snack item with
the test fat incorporated was served with either plain tea
or coffee. A sample day’s menu for example providedTable 1 Subject characteristics (n = 15)
Characteristics Mean values ± sd




Weight (kg) 56.6 ± 12.8
BMI (kg/m2)
All 21.8 ± 2.30
Male 22.27 ± 2.93
Female 20.99 ± 2.16
% Body fat
All 23.54 ± 6.53
Male 18.85 ± 6.27
Female 28.05 ± 4.70
Plasma total cholesterol (mmol/L) 5.26 ± 0.78
Plasma triacylglycerol (mmol/L) 1.15 ± 0.60
Plasma LDL cholesterol (mmol/L) 3.09 ± 0.62
Plasma HDL cholesterol (mmol/L) 1.64 ± 0.27fried noodles and doughnut for breakfast, followed by
sweet and sour fish, spicy fried egg plant and stir fried
green vegetables served with rice for lunch whilst sub-
jects consumed cake and fried spring rolls for high tea.
To maximize compliance, volunteers were provided with
the test oils for preparing dinner as well as weekend
meals at home. This 7-day period of dietary standar-
dization minimized any variation in dietary fatty acid
consumption before the postprandial investigations. A
wash-out period of one week was allowed between the
test rotations. Subjects were asked to eat according to
their individual caloric plan as calculated by the die-
titian. Body weight measurements were recorded before
each postprandial challenge to ensure weight fluctua-
tions were minimized between test meal rotations.
Test diets and test oils
The P/S ratios of the diets were constructed by using
palm olein in varying concentrations with other natural
edible oils. The low P/S or POL diet (P/S = 0.27) was de-
rived wholly from palm olein. This was compared to the
American Heart Association-Step 1 or AHA diet (P/S =
1.0; palm olein and soybean oil blend) and a high P/S
monounsaturated oil blend or PCAN diet (P/S = 1.32;
palm olein and canola oil blend). The daily menu during
the 7-day run-in period provided approximately 50g of
the test fat in the diet equivalent to ~26% en. Thus total
daily fat content of test meals provided during each of
these periods was maintained at 31% en with the non-
test fat contribution (~5% en) coming from dietary
sources of invisible fats. All diets were eucaloric and
only differed in their P/S ratios as demonstrated by the
fatty acid composition of the test oils used for preparing
the meals and actual analysis of the double portioned
menus (Table 2).
Postprandial challenge
Following the 7-day preconditioning, volunteers repor-
ted to the laboratory on the morning of the 8th day after
an overnight fast of 10 h. A 12-ml fasted venous blood
sample was obtained from the subjects. Subjects then
completed consumption of a standard breakfast meal
containing 50g of the test oil within 15 minutes of their
baseline bleed. This meal consisted of 275 g of fried rice
with 2 portions of breaded snack which provided ap-
proximately 1010 kcal, 101 g carbohydrate (40% en),
53 g fat (47% en) and 32g protein (13% en) (Table 3).
Plain tea and coffee was allowed with the test meal. Sub-
jects remained rested and in a fasted state throughout
the 7-h postprandial period with blood drawing by
venous puncture performed sequentially at 1.5, 3.5, 5.5
and 7.0 h after the fat challenge. The same sequence of
blood sampling for all timed events was followed during
each postprandial challenge. Blood sampling at each




Test Oils (% total fat1) Test Diets (% total en2)
POL AHA PCAN POL AHA PCAN
C12:0 0.25 0.11 nd nd 0.12 0.1
C14:0 0.84 0.39 0.21 nd 0.45 0.38
C16:0 37.07 20.94 10.56 38.62 22.01 13.49
C16:1n7 0.08 0.07 nd nd 0.05 0.07
C18:0 3.94 3.75 2.07 3.7 3.92 2.92
C18:1 44.86 40.1 58.09 46.08 40.42 55.22
C18:2 11.03 27.93 18.77 11.6 26.15 18.07
C18:3 0.23 4.18 6.47 nd 3.65 5.1
SFA 42.22 25.88 14.05 42.32 27.16 17.89
PUFA 11.38 32.25 25.5 11.6 30.01 23.6
MUFA 45.1 40.29 58.27 46.08 41.15 56.28
P/S 0.27 1.25 1.81 0.27 1.10 1.32
1 values reported as percent of total fat in the meal.
2 % total en = as percent energy of total fat in the meal.
POL Palm olein, AHA Soybean-Palm olein blend, PCAN Rapeseed-Palm olein
blend, nd not detectable, SFA saturated fatty acid, MUFA monounsaturated
fatty acid, PUFA polyunsaturated fatty acid, nd not detectable, P/S ratio
polyunsaturated/saturated fatty acid ratio.
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of beginning the session. Mineral water consumption
was permitted ad libitum throughout this period.Analytical methods
Blood collection
Blood was collected into Vaccutainer® tubes (Becton
Dickinson Vacutainer, Franklin Lakes, NJ, USA) con-
taining EDTA (0.117 ml of 15% EDTA) and immediately
centrifuged at 3000 × g for 20 min at 4°C (Sigma 3K12
B. Braun, Tuttlingen, Germany) to separate the plasma
from red blood cells. About 3.0 ml of fresh plasma was
reserved for ultracentrifugation whilst the remaining
plasma was aliquoted and snap-frozen in liquid nitrogen
and stored at −80°C for subsequent analyses.Table 3 Analyzed nutrient content of postprandial meal
Nutrient content Means +/- SD
Total Energy (kcal) 1010 ± 250
Fat (g) 53.08 ± 16.25
% Fat energy 47.13 ± 7.29
Protein (g) 32.03 ± 11.00
% Protein energy 12.74 ± 3.68
Carbohydrate (g) 101.01 ± 30.15
% Carbohydrate energy 40.13 ± 6.03
Note- Energy value based on bomb calorimetry.
Macronutrient values based on proximate analysis.Chylomicron separation
Ultracentrifugation of fresh EDTA plasma to separate
the upper fraction containing triacylglycerol-rich lipo-
proteins (TRL) and HDL-C-rich bottom fractions was
carried out in sealed Beckman Quick-Seal® polyallomer
tubes (Beckman Instruments Inc., Palo Alto, CA, USA).
Our laboratory technique for tube preparation and lipo-
protein separation has been described elsewhere [22].
Three ml of fresh plasma was used and at the end of
ultracentrifugation, tubes were sliced at the point of
sealing, and aliquots removed in sequence. The bottom
fraction was made up to a final volume of 3.0 ml with
NaCl solution (d > 1.006 g/ml). This fraction was subse-
quently used to determine HDL-C concentration (d =
1.063 g/ml) as well as to characterize plasma cholesteryl
ester (CE) FAC.
Lipid and Lipoprotein assays
TC in plasma and bottom fractions of ultracentrifuged
plasma and plasma TAG were determined by enzymatic
procedures [24,25]. HDL-C was precipitated with dextran
sulfate- Mg2+ before assaying [26,27]. All assays were
performed using a Cobas 6000 Chemistry Autoanalyzer
System (Roche Analytic Instruments Inc, Nutley, NJ).
Reagents, calibrators and controls were also supplied by
the manufacturer (Roche Diagnostics Corporation,
Indianapolis, IN). Plasma LDL-C was calculated by the
differences between cholesterol content of the bottom
fraction of ultracentrifuged plasma and HDL-C [28].
Determination of fatty acid composition (FAC)
Extracted lipids from TRL, CE and test meals were
converted into fatty acid methyl esters before gas liquid
chromatography for the determination of FAC (Perkin-
Elmer Autosystem, Perkin-Elmer, Norwalk, CT, USA).
The procedures have been described in detail elsewhere
[22]. The FAC of the meals consumed by the subjects
served to check whether the test meals achieved targeted
FAC whilst the FAC of subjects’ plasma served to check
compliance to the study protocol.
Statistical analysis
The cross-over design enabled each subject to serve as
his or her own control and all 15 subjects completed the
3 test meal rotations. The Statistical Package for Social
Sciences, SPSS® for Windows™ application (Version 15.0,
SPSS Inc., Chicago, IL., USA) was used for the required
statistical analyses. Differences between outcomes from
the various postprandial time intervals and baseline
values (0 h) were interpreted as true measures of change
resulting from dietary treatment. Multivariate analyses
for repeated measures (MANOVA), using the general
linear model (GLM), was performed for all time × test





















































Figure 1 Plasma TAG concentrations in response to test meals.
A: Plasma TAG (means ± SEM, n = 15) concentrations over 7 h in
response to test meals containing POL, AHA or PCAN oil type.
Repeated measures MANOVA analyzed for time x test meal
interactions was not significant (P > 0.05) between treatments
despite an observed trend (POL > AHA > PCAN). B: Univariate
analyses for AUC data for plasma TAG trends was not significant
between test meals (P > 0.05). In comparison AUC increased by
22.58% after the POL treatment and by 7.63% after the PCAN
treatment compared to the AHA treatment. Legends (A):
POL = Palm olein only ( ); AHA = Soybean-
Palm olein blend ( ); PCAN = Rapeseed-Palm
olein blend ( ).
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(AUC) derived for the 7 h duration of the postprandial
period calculated by the trapezoidal rule [29]. Levene’s
Test was used to examine equality of variances across
treatment groups. Bonferroni’s adjustment for multiple
paired comparisons was used to test mean differences
between treatment groups. Significance was set at P <
0.05 for all evaluated measures.
Results
Subject demographics
Mean (± SD) gain in body weight amounting to 0.97 ±
0.81 kg which was less than 2% of mean body weight at
the start of the study was not significant [data not
shown].
Lipemic response and test fat clearance
Based on postprandial plasma TAGs [Figure 1A], al-
though a higher degree of lipemia was observed with de-
creasing P/S ratio (POL > AHA > PCAN) the effect of
time × meal treatment changes was not significant (P >
0.05). TAG trends for all meals did not reach post-
absorptive levels at 7h indicating fat clearance was not
yet completed. AUC calculations indicated a lack of sig-
nificance (P > 0.05) between meals [Figure 1B]. However
TAG AUC increased by 22.58% after the POL meal and
by 7.63% after the PCAN meal compared to the AHA
meal (Table 4).
Plasma TC, VLDL-C, LDL-C and HDL-C
Data for lipoprotein response as a result for diet is
presented in Table 4. No change in time × meal treat-
ment effects were observed in postprandial TC concen-
trations as a result of P/S ratio manipulation of the test
meal challenges (P > 0.05).
Varying the P/S ratios of meal challenges significantly
altered (P < 0.001) prandial time × meal treatment
changes in plasma HDL-C concentrations with an ob-
served increasing trend of concentrations with decreas-
ing P/S ratio (POL > AHA > PCAN) [Figure 2A]. The
prandial increase for HDL-C was greater for POL com-
pared to AHA (P = 0.005) and PCAN (P < 0.001) meals.
This was substantiated by a significantly higher HDL-C
AUC response for POL compared to AHA (P > 0.05) and
PCAN (P = 0.009) meals which was measurably greater
by 25.38% for POL compared to PCAN whilst AHA in-
creased by 16.0% compared to POL [Figure 2B].
Postprandial LDL-C response in terms of time X meal
treatment effects was significantly lowest after the POL
treatment (P = 0.005) compared to AHA and PCAN with
stronger differences between the POL and PCAN pair
(P = 0.004) compared to POL and AHA (P > 0.05) or
AHA and PCAN (P > 0.05) pairs. AUC for LDL-C re-
mained unaffected by the P/S nature of the diets (P >0.05).A similarly lower trend for plasma VLDL-C (P = 0.032) for
diet treatment × time interactions was observed with dif-
ferences between POL compared to AHA (P > 0.05) and
PCAN (P = 0.030). AUC for VLDL-C was affected by the
P/S nature of the diets (P =0.017) and only mediated by
the difference between POL and PCAN (P = 0.014).
Fatty acid composition (FAC) of TRL and CE
The effect of time was not significant after correction
for the baseline values for individual fatty acids in both
TRL and CE. Figures 3A-F show the distribution of indi-
vidual fatty acids (mean ± SE) in TRL, expressed as a
percentage of the FAC. A significant effect of dietary
Table 4 Postprandial lipid and lipoprotein cholesterol concentrations in response to single meal fat challenges with
varying P/S ratios








Plasma Total Cholesterol (mmol/L) 1
POL 5.58± 0.84 5.07 ± 0.81 5.32 ± 0.91 5.32 ± 0.83 5.43 ± 0.71 2224.38 ± 283.82 ns ns ns
AHA 5.76 ± 0.97 5.41 ± 1.19 5.49 ± 0.88 5.53 ± 0.98 5.39 ± 1.26 2310.38 ± 400.11
PCAN 5.38 ± 1.21 5.25 ± 1.16 5.10 ± 1.03 5.51 ± 1.32 5.38 ± 1.36 2225.77 ± 482.45
Plasma HDL-C (mmol/L) 1
POL 1.31 ± 0.31 1.57 ± 0.40 1.52 ± 0.29 1.54 ± 0.40 1.52 ± 0.36 635.61 ± 126.73 P = 0.005 P <0.001 ns
AHA 1.21 ± 0.37 1.34 ± 0.51 1.31 ± 0.35 1.21 ± 0.36 1.20 ± 0.37 533.93 ± 155.34
PCAN 1.13 ± 0.33 1.16 ± 0.33 1.10 ± 0.31 1.12 ± 0.38 1.16 ± 0.37 474.30 ± 137.91
Plasma LDL-C (mmol/L) 1
POL 3.69 ± 0.92 2.71 ± 0.77 2.58 ± 1.22 2.51 ± 1.12 2.82 ± 0.80 1258.63 ± 257.86 ns P =0.004 ns
AHA 4.00 ± 0.86 3.45 ± 1.13 3.21 ± 0.87 3.24 ± 1.08 3.37 ± 1.23 1442.58 ± 354.17
PCAN 3.63 ± 1.16 3.30 ± 0.97 2.96 ± 0.98 3.33 ± 1.18 3.41 ± 1.16 1374.91 ± 419.73
Plasma Triacylglyceride (mmol/L) 1
POL 1.26 ± 0.74 1.71 ± 0.67 2.66 ± 1.35 2.77 ± 1.81 2.37 ± 1.71 952.07 ± 496.11 ns ns ns
AHA 1.19 ± 0.60 1.37 ± 0.58 2.12 ± 1.13 2.35 ± 1.45 1.76 ± 1.25 776.67 ± 411.35
PCAN 1.36 ± 0.86 1.72 ± 0.73 2.26 ± 0.99 2.32 ± 1.18 1.78 ± 1.30 835.91 ± 374.58
Plasma VLDL-C (mmol/L) 1
POL 0.49 ± 0.17 0.91 ± 0.18 0.82 ± 0.27 0.91 ± 0.15 1.05 ± 0.33 358.44 ± 54.56 ns P =0.030 ns
AHA 0.48 ± 0.28 1.13 ± 0.38 0.95 ± 0.34 1.10 ± 0.35 1.32 ± 0.42 428.59 ± 79.40
PCAN 0.51 ± 0.15 1.20 ± 0.35 1.14 ± 0.57 1.26 ± 0.56 1.36 ± 0.88 479.50 ± 165.90
POL Palm olein, AHA Soybean-Palm olein blend, PCAN Rapeseed-Palm olein blend.
n = 15; 1means ± SD; 2Bonferroni’s pair-wise analysis for between diets comparisons; ns = P <0.05.
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oleic (C18:1), linoleic (C18:2) and linolenic (C18:3) acids
in the composition of TRL but not for palmitoleic
(C16:1n7) and stearic (C18:0) acids.
Incorporation of C16:0 in TRL was greatest after the
POL test meal compared to either AHA and PCAN
meals (P < 0.001) as expected due to its greater dietary
availability (POL = 38.6%; AHA = 22.0%; PCAN = 13.5%)
and this pattern was also reflected in its greater incorp-
oration into TRL content after the AHA meal compared
to the PCAN meal (P = 0.029). Percent C18:1 in TRL
(P < 0.001) also reflected dietary availability (POL =
46.1%; AHA = 40.4%; PCAN = 55.2%) and incorporation
appeared to be dose–dependent with PCAN > POL (P <
0.001), PCAN > AHA (P < 0.001) and POL = AHA (P >
0.05). Presence of C18:2 in TRL was significantly higher
after the AHA treatment compared to the POL (P =
0.001) and PCAN (P = 0.046) treatments and this was
dependent on the C18:2 content of the test meals
(POL = 11.6%; AHA = 26.2%; PCAN = 18.1%). Treatment
effects on C18:2 incorporation into TRL after PCAN
and POL meals were not significantly different (P >
0.05). C18:3 was present in the AHA (3.7%) and PCAN
(5.1%) meals only and TRL incorporation thereforereflected this dietary availability with both PCAN and
AHA treatment effects significantly greater than POL
(P < 0.001) treatment but not between themselves (P >
0.05). Of interest was the observation that these changes
in plasma TRL FAC were already apparent when blood
was sampled at 1.5 h post-meal challenge and continued
with only negligible changes throughout the 7 h experi-
mental duration.
Individual fatty acid concentrations in CE as percent
FAC, in response to the varying P/S ratio test meals are
presented in Figures 4A-F. Significant differences in CE
fatty acids after correction for baseline values were evi-
dent for palmitic (C16:0, P < 0.05), oleic (C18:1, P =
0.017), linoleic (C18:2, P = 0.001) and linolenic (C18:3,
P < 0.001) acids in the composition of TRL but not for
palmitoleic (C16:1n7) and stearic (C18:0) acids (P >
0.05). The appearance of these fatty acids in CE reflected
meal source but were independent of test meal × time
interactions.
Discussion
Fatty acid compositional analysis established chylo-
micron triacylglycerols (TAGs) closely followed the test






























































Figure 2 Plasma HDL-C concentrations in response to test
meals. A: Plasma HDL-C (means ± SEM, n = 15) concentrations over
7 h in response to test meals containing POL, AHA or PCAN test fats.
Varying the P/S ratios of test fat challenges significantly altered
prandial plasma HDL-C concentrations (P < 0.001) when tested by
repeated measures MANOVA analysis of time x meal interactions.
Plasma HDL-C concentrations increased with decreasing P/S ratio
(POL > AHA > PCAN). Bonferroni’s testing indicated significance for
paired comparisons between POL with AHA (a, P = 0.005) and PCAN
(b, P < 0.001) meals but not between AHA and PCAN (P > 0.05)
meals. B: Univariate analysis indicated AUC for HDL-C AUC was
greater after POL compared to PCAN (a, P = 0.009) and AHA
(P > 0.05) meals. HDL-C AUC increased by 25.38% for POL
compared to PCAN and 16.0% for AHA compared to PCAN
meals. Legends (A): POL = Palm olein only ( );
AHA = Soybean-Palm olein blend ( ); PCAN =
Rapeseed-Palm olein blend ( ).
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valid tool for compliancy measures [30]. The dietary fats
in this study incorporated palm olein in varying propor-
tions to achieve P/S ratios ranging from 0.27 (palm olein
only), 1.0 Step 1 or AHA recommendation (palm olein
with soyabean oil) which has a higher content of n-6PUFA and 1.32 targeting a higher MUFA (palm olein +
rapeseed oil) content which is the therapeutic lifestyle
change (TLC) diet advocated by the ATP III guidelines.
The overall fatty acid composition ratio of SFA:PUFA:
MUFA achieved a proportion of 3.5:1:3.8 for the POL
diet, 1:1.1:1.5 for the AHA diet and 1:1.3:3 for the PCAN
diet. Palm oil in varying proportions allowed for the
MUFA content to be kept constantly > 40% for all diets
with only the proportion of palmitic acid as a SFA source
and linoleic acid as a PUFA source differing between diets.
This study found that varying the P/S ratio did not sig-
nificantly affect plasma TC and TAG levels postpran-
dially. Plasma HDL-C concentrations were significantly
affected by the P/S ratio of the diets tested. HDL-C con-
centrations increased with the POL diet (P/S = 0.27) but
were lowered with the AHA (P/S = 1.0) and PCAN
(P/S = 1.3) diets. A consequence of decreasing dietary fat
saturation in humans is the concomitant decrease in
HDL-C concentrations in both adult and pediatric po-
pulations [31-34]. In long-term studies it has been hy-
pothesized that the lowering of HDL-C with increasing
unsaturation was a consequence of isoenergetic substi-
tution with carbohydrates [35-37]. We however kept
carbohydrate content of all test diets constant, and the
only dietary parameters that were interchanged were the
SFA and n-6 PUFA content. Percentage increase in AUC
plasma HDL-C for the POL diet compared to the PCAN
diet was 31.4% whilst the increase for the AHA diet
compared to the PCAN diet was only 8.4%. The increase
in HDL-C caused by the POL diet during the post-
prandial period compared to the higher P/S diets may
indicate an ability of the POL diet to promote reverse
cholesterol transport (RCT). However, study limita-
tions prevented the inclusion and evaluation of pa-
rameters such as HDL particle size or the enzymes
involved in RCT such as cholesteryl ester transfer
protein, lipoprotein lipase and lecithin:cholesteryl acyl
transfer protein [38].
We observed a monophasic lipemic response irre-
spective of P/S ratios with peaking taking place between
3.5-5.5 h and the associated lipemia was not significantly
different between test meals. However, the magnitude
and duration of lipemia was greatest with the POL diet
but lesser with oils of increasing P/S ratio. The mono-
phasic pattern of postprandial TAG behaviors in this
study is in variance with other studies which report
peaking either once, twice or three times during the
postprandial period [39-41]. A biphasic response has
also been associated with increasing MUFA content after
a single meal challenge [40]. In a study comparing palm
oil, lard and puff pastry margarine, Jensen et al. reported
a biphasic response curve with an initial peak 1-2 h and
a second peak 4-7 h after the meal [40]. But the diet used






















































































































































Figure 3 Fatty acid composition (FAC) of triacylglycerol (TAG) in triacylglycerol-rich lipoproteins (TRL) (mean % ± SEM, n = 15) in
response to test meals containing POL, AHA or PCAN test fats. 2Statistical analyses were corrected for baseline values and significance
reported at P < 0.05 for time x meal interactions. A: Percent C16:0 trends after 1.5 h were significantly greater after the POL meal compared to
AHA and PCAN meals (ab, P < 0.001), followed by the AHA meal and least after the PCAN meal (c, P = 0.029). B: Percent C16:1n7 incorporation
into TRL TAG was not significantly different between treatments (P > 0.05). C: Percent C18:0 incorporation into TRL TAG was not significantly
different between treatments (P > 0.05). D: Percent C18:1 significantly increased after the PCAN meal compared to POL (a, P = 0.001) and AHA
(b, P < 0.001) meals whereas the comparison between POL and AHA were not significantly different (P > 0.05). E: Percent C18:2 significantly
increased the most after AHA meal compared to PCAN (a, P = 0.037) and POL (b, P = 0.001) meals. The comparison between PCAN and POL was
not significantly different (P > 0.05). F: Percent C18:3 significantly increased the most after PCAN meal compared to AHA (P > 0.05) and POL
(a, P < 0.001) meals. The comparison between AHA and POL was also significantly different (b, P < 0.001). Legends (A-F): POL = Palm olein only
( ); AHA = Soybean-Palm olein blend ( ); PCAN = Rapeseed-Palm olein blend ( ).
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http://www.nutritionj.com/content/12/1/122carbohydrates providing 83% energy; protein providing
10% energy). This was in stark contrast to the nutritional
content of the postprandial meal supplied in this study
(total energy 1010 kcal, 101 g carbohydrate, 53 g fat
and 32 g protein) .
In agreement with our study, Pedersen et al. (1999) in
comparing rapeseed oil, sunflower oil and palm oil as
sources of MUFA, PUFA and SFA respectively, did
not find significant differences between fat classes in re-
lation to fat clearance and lipoprotein response [42].
Weintraub et al. (1988) also did not report any signifi-
cant difference in TAG levels between SFA and n-6
PUFA diets [20]. However others have noted slower
postprandial fat clearance of long-chain SFAs comparedto n-6 PUFAs [19,21,43] whilst n-3 PUFA had the ability
to markedly attenuate lipemia compared to SFA and n-6
PUFA diets [21]. Preferential hydrolysis by lipoprotein
lipase for larger TRL particles has been reported in rat
studies [44,45]. Therefore the lower lipemia caused by
the AHA and PCAN diets compared to the POL diet
may perhaps be explained by the particle size of TRLs
which is increased by unsaturated fatty acids compared
to SFAs [18,20].
The major finding of this postprandial human study
was the post-meal effect of increasing HDL-C levels oc-
curred with a decreasing P/S ratio which was achieved
with a higher palmitic acid content. This finding is in ag-









































































































































Figure 4 Fatty acid composition (FAC) of plasma cholesteryl esters (CE) (mean % ± SEM, n = 15) in response to test meals containing
POL, AHA or PCAN test fats. 2Statistical analyses were corrected for baseline values and significance reported at P < 0.05 for time x test meal
interactions. A: Percent C16:0 in TRL CE significantly increased after the POL meal compared to the AHA meal (a, P = 0.043) but was not
significantly different compared to the PCAN (P > 0.05) meal. The comparison between AHA and PCAN meals was not significantly different
(P > 0.05). B: Percent C16:1n7 incorporation into TRL CE was not significantly different between meals (P > 0.05). C: Percent C18:0 incorporation
into TRL CE was not significantly different between meals (P > 0.05). D: Percent C18:1 in TRL CE was significantly greater after POL (a, P = 0.002)
and PCAN meals (b, P = 0.001) compared to the AHA meal whereas the comparison between POL and PCAN was not significantly different
(P > 0.05). E: Percent C18:2 in TRL CE increased the most after the AHA meal compared to POL (P < 0.05) and PCAN (a, P = 0.017). The comparison
between POL and PCAN was not significantly different (P > 0.05). F: Percent C18:3 incorporation into TRL CE was the most after the PCAN meal
compared to AHA (a, P < 0.001) and POL (b, P < 0.001) meals whereas it was least after the POL meal. The comparison between POL and AHA
meals was also significantly different (c, P < 0.001). Legends (A-F): POL = Palm olein only ( ); AHA = Soybean-Palm olein blend
( ); PCAN = Rapeseed-Palm olein blend ( ).
Karupaiah and Sundram Nutrition Journal 2013, 12:122 Page 9 of 11
http://www.nutritionj.com/content/12/1/122oil) which suggest an association of palmitic acid with
greater HDL-C levels and lower TC/HDL-C [46-48]. In-
creased HDL-C levels are cardioprotective with an anti-
atherogenic benefit associated with its primary role in
reverse cholesterol transport. A 1% increase in HDL-C re-
sults in a 1 to 2% reduction in major cardiovascular events
[49]. Raising HDL-C is now a treatment goal for athero-
genic dyslipidemia in CVD risk management in addition
to reducing LDL-C [50,51]. This area of research is intense
and remains complex as noted from the negative resultsassociated with nicotinic acid or fibrate in combination
therapy with statin [52]. The evidence from alternative ef-
forts such as promoting exercise, moderate alcohol use,
weight loss and smoking cessation as a means to promote
HDL-C is scarce. Dietary factors that affect HDL-C re-
main to be identified [53].
Conclusions
Lower P/S ratios of dietary fat blends using palm olein
were associated with an increasing but non-significant
Karupaiah and Sundram Nutrition Journal 2013, 12:122 Page 10 of 11
http://www.nutritionj.com/content/12/1/122lipemic trend in humans. On the other hand decreasing
P/S ratios of these dietary fat blends were associated
with a significantly greater prandial HDL-C trend. Al-
though these data are important and interesting on their
own merit, we recommend that that these effects should
also be retested in trials with longer feeding periods and
in subjects with more severe form of hyperlipidemia.
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